B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

TYK2

MOLECULAR TARGET

tyrosine kinase 2

UniProt: P29597NCBI Gene: 729766 compounds

TYK2 (tyrosine kinase 2) is targeted by 66 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting TYK2

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1erlotinib5.55256
2imatinib5.47236
3sb 2035804.92136
4tofacitinib4.65104
5alvocidib4.5291
6foretinib4.3476
7tozasertib4.3375
8ruxolitinib4.2368
9pi 1034.1764
10bosutinib4.0858
11midostaurin3.8546
12silmitasertib3.7843
13pazopanib3.6939
14nintedanib3.6136
15baricitinib3.5634
166bio3.5032
17tae 6843.4330
18fedratinib3.4029
19dovitinib3.0921
20jnj 77066213.0921
21at 92833.0921
22upadacitinib3.0921
23lestaurtinib3.0420
24pacritinib3.0420
25filgotinib3.0420
26momelotinib2.8917
27r 4062.8316
28infigratinib2.7715
29hesperadin2.7715
30pha 6657522.7114
31enmd 20762.7114
32bms 3455412.7114
33kw 24492.6413
34ast 4872.5612
35raf 2652.4811
36defactinib2.4811
37deucravacitinib2.4811
38azd 14802.309
39reversine2.309
40su 0148132.208
41decernotinib2.208
42gandotinib2.208
43cyc 1162.087
44tg100 1152.087
45cerdulatinib1.956
46itacitinib1.956
47delgocitinib1.956
48pf 038147351.795
49abrocitinib1.795
50Crizotinib1.393

Showing top 50 of 66 compounds. Use the BiohacksAI search to explore all TYK2 modulators.

About TYK2 as a Drug Target

TYK2 (tyrosine kinase 2) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 66 compounds with documented TYK2 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

TYK2 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.